Sertraline in stroke-associated lability of mood
Completed
Phase N/A ResultsSummary of Purpose
To assess whether a selective serotonin reuptake inhibitor is effective in the treatment of stroke-associated lability of mood.
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 21 September 2001.
Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Design
Double-blind, randomized, placebo-controlled, parallel group trial of 28 patients at 3 centers.
Contacts
-
Alistair Burns, Department of Old Age Psychiatry, Withington Hospital, West Didsbury, Manchester M20 8LR, UK.
A_Burns@fs1.with.man.ac.uk
Recruitment
- Gender: Both
- Study Size: 28
- Number of Centers: 3
- Follow Up: 3 Months
Principal Investigator
-
Alistair Burns
Department of Old Age Psychiatry, Withington Hospital, Manchester, UK
Locations
- Manchester, UK.